SCHEMBL6203665

SCHEMBL6203665

CS(=O)(=O)Oc1ccc2c(C(=O)c3ccc(OCCC4CCCCN4)cc3)c(-c3ccc(F)cc3CO)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.40
SSTR2 P30874 7/20 0.36
ENPP3 O14638 4/20 0.34
ENPP1 P22413 1/20 0.34
LTA4H P09960 2/20 0.34
AURKB Q96GD4 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32
HTR1D P28221 1/20 0.32
HTR1B P28222 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6004786 0.92 CHEK2 (0.41) CHEK2SSTR2ENPP3ENPP1LTA4H
SCHEMBL6004662 0.89 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1LTA4H
SCHEMBL6203386 0.88 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1LTA4H
SCHEMBL6204827 0.87 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1LTA4H
SCHEMBL6204189 0.85 CHEK2 (0.44) CHEK2SSTR2LTA4HAURKBHSP90AA1
SCHEMBL6004833 0.85 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1LTA4H
SCHEMBL5422570 0.83 ENPP3 (0.51) ENPP3ENPP1
SCHEMBL6003394 0.82 CHEK2 (0.43) CHEK2SSTR2LTA4HAURKB
SCHEMBL6246289 0.82 CHEK2 (0.43) CHEK2SSTR2
SCHEMBL6003300 0.82 CHEK2 (0.43) CHEK2SSTR2LTA4HAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551822-A2 PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 2005-07-13 EP disclosed
WO-2004009578-A2 PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 2004-01-29 WO disclosed